Novartis Pharmaceuticals Corp. v. Torrent Pharma Inc., decided 10 Jan 25 episode artwork

EPISODE · Mar 19, 2025 · 17 MIN

Novartis Pharmaceuticals Corp. v. Torrent Pharma Inc., decided 10 Jan 25

from CAFC News Brief · host Sentinel

This case centered on the validity of Novartis's patent for Entresto, a heart failure medication. The lower court found the patent invalid for lack of written description, but the appeals court reversed this decision, finding the patent adequately described the claimed invention. The appeals court upheld the lower court's findings that the patent claims were not obvious or lacking enablement. The dispute involved the construction of the claim term "administered in combination," impacting whether the patent covered a complexed or uncomplexed form of the drug.

NOW PLAYING

Novartis Pharmaceuticals Corp. v. Torrent Pharma Inc., decided 10 Jan 25

0:00 17:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of CAFC News Brief?

This episode is 17 minutes long.

When was this CAFC News Brief episode published?

This episode was published on March 19, 2025.

What is this episode about?

This case centered on the validity of Novartis's patent for Entresto, a heart failure medication. The lower court found the patent invalid for lack of written description, but the appeals court reversed this decision, finding the patent adequately...

Can I download this CAFC News Brief episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!